Gastrointestinal pH, Motility Patterns, and Transit Times After Roux-en-Y Gastric Bypass.

Gastric bypass Gastrointestinal pH Gastrointestinal transit Motility Pharmacotherapeutics Smartpill Wireless motility capsule

Journal

Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714

Informations de publication

Date de publication:
06 2021
Historique:
received: 21 12 2020
accepted: 23 02 2021
revised: 17 02 2021
pubmed: 13 3 2021
medline: 21 5 2021
entrez: 12 3 2021
Statut: ppublish

Résumé

Studies investigating the underlying pathophysiology are needed to help explain and understand the postoperative complications following Roux-en-Y gastric bypass (RYGB) surgery. This study aimed to characterize segmental gastrointestinal pH profiles, motility measures, and transit times in patients with RYGB. Nineteen patients with RYGB underwent a standardized wireless motility capsule assessment. The oro-cecal segment was defined from capsule ingestion until the passage of the ileocecal junction. Segmental median pH, motility index, and transit time were determined for the oro-cecal and colonic segment as well as for the first and last hour of both these segments. For comparison to reference values, data from 17 healthy age- and gender-matched controls was used. A mixed effect model was used to describe differences between groups. Median pH was high in patients with RYGB during the first hour of the oro-cecal segment (6.45 ± 0.4 vs 3.65 ± 1.55 pH units for healthy controls; P < 0.001), as well as during the entire oro-cecal segment (6.97 ± 0.4 vs 5.51 ± 1.1 pH units; P < 0.001). The same was evident for the median motility index (152 ± 64 vs 35.8 ± 31.1 mmHg*sec/min; P < 0.001 and 130 ± 65.9 vs 89.1 ± 20 mmHg*sec/min; P < 0.012, respectively). Median motility index was low the first hour of the colon (55.2 ± 45.7 vs 122 ± 77.9 mmHg*sec/min; P < 0.002). Additionally, patients had short oro-cecal transit time (5.8 ± 1.6 vs 7.6 ± 1.4 h; P < 0.001) and long colonic transit time (29.4 ± 17.5 vs 19.6 ± 12.2 h; P = 0.048). In patients with RYGB, the oro-cecal segment was characterized by an alkaline intraluminal environment, high motility activity, and short transit time. In contrast, colonic transit time was long.

Sections du résumé

BACKGROUND
Studies investigating the underlying pathophysiology are needed to help explain and understand the postoperative complications following Roux-en-Y gastric bypass (RYGB) surgery. This study aimed to characterize segmental gastrointestinal pH profiles, motility measures, and transit times in patients with RYGB.
MATERIALS AND METHODS
Nineteen patients with RYGB underwent a standardized wireless motility capsule assessment. The oro-cecal segment was defined from capsule ingestion until the passage of the ileocecal junction. Segmental median pH, motility index, and transit time were determined for the oro-cecal and colonic segment as well as for the first and last hour of both these segments. For comparison to reference values, data from 17 healthy age- and gender-matched controls was used. A mixed effect model was used to describe differences between groups.
RESULTS
Median pH was high in patients with RYGB during the first hour of the oro-cecal segment (6.45 ± 0.4 vs 3.65 ± 1.55 pH units for healthy controls; P < 0.001), as well as during the entire oro-cecal segment (6.97 ± 0.4 vs 5.51 ± 1.1 pH units; P < 0.001). The same was evident for the median motility index (152 ± 64 vs 35.8 ± 31.1 mmHg*sec/min; P < 0.001 and 130 ± 65.9 vs 89.1 ± 20 mmHg*sec/min; P < 0.012, respectively). Median motility index was low the first hour of the colon (55.2 ± 45.7 vs 122 ± 77.9 mmHg*sec/min; P < 0.002). Additionally, patients had short oro-cecal transit time (5.8 ± 1.6 vs 7.6 ± 1.4 h; P < 0.001) and long colonic transit time (29.4 ± 17.5 vs 19.6 ± 12.2 h; P = 0.048).
CONCLUSIONS
In patients with RYGB, the oro-cecal segment was characterized by an alkaline intraluminal environment, high motility activity, and short transit time. In contrast, colonic transit time was long.

Identifiants

pubmed: 33709293
doi: 10.1007/s11695-021-05308-x
pii: 10.1007/s11695-021-05308-x
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2632-2640

Références

Tremmel M, Gerdtham U-G, Nilsson P, et al. Economic burden of obesity: a systematic literature review. Int J Environ Res Public Health. 2017;14:435.
pmcid: 5409636 doi: 10.3390/ijerph14040435 pubmed: 5409636
World Health Organization. Obesity and overweight. 2018 [cited 2019 Aug 22]. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight . Accessed 22 Aug 2020.
Sundhedsstyrelsen. National Klinisk Retningslinje for fedmekirurgi. Vol. 150, InPharma. 2013 [cited 2019 Apr 10]. 9–10 p. Available from: http://www.sst.dk .  Accessed 10 April 2020.
Carlsson LMS, Sjöholm K, Jacobson P, et al. Life expectancy after bariatric surgery in the Swedish obese subjects study. N Engl J Med. 2020;383:1535–43.
pubmed: 33053284 pmcid: 7580786 doi: 10.1056/NEJMoa2002449
Dimitriadis GK, Randeva MS, Miras AD. Potential hormone mechanisms of bariatric surgery. Curr Obes Rep. 2017;6:253–65.
pubmed: 28780756 pmcid: 5585994 doi: 10.1007/s13679-017-0276-5
Seeras K, Lopez PP. Roux-en-Y gastric bypass chronic complications. StatPearls. 2019 [cited 2019 Jul 16];Available from: http://www.ncbi.nlm.nih.gov/pubmed/30137773 .  Accessed 16 July 2020.
Angeles PC, Robertsen I, Seeberg LT, et al. The influence of bariatric surgery on oral drug bioavailability in patients with obesity: a systematic review. Obes Rev. 2019;20:1299–311.
pubmed: 31232513 pmcid: 6852510 doi: 10.1111/obr.12869
Hedberg J, Hedenström H, Sundbom M. Wireless pH-metry at the gastrojejunostomy after Roux-en-Y gastric bypass: a novel use of the BRAVO™ system. Surg Endosc. 2011;25:2302–7.
pubmed: 21298531 doi: 10.1007/s00464-010-1553-5
Hedberg J, Hedenström H, Nilsson S, et al. Role of gastric acid in stomal ulcer after gastric bypass. Obes Surg. 2005;15:1375–8.
pubmed: 16354514 doi: 10.1381/096089205774859380
Mason EE, Munns JR, Kealey GP, et al. Effect of gastric bypass on gastric secretion. Surg Obes Relat Dis. 2005;1:155–60.
pubmed: 16925234 doi: 10.1016/j.soard.2005.02.014
Dirksen C, Damgaard M, Bojsen-Møller KN, et al. Fast pouch emptying, delayed small intestinal transit, and exaggerated gut hormone responses after Roux-en-Y gastric bypass. Neurogastroenterol Motil. 2013;25:346–e255.
pubmed: 23360316 doi: 10.1111/nmo.12087
Nguyen NQ, Debreceni TL, Burgstad CM, et al. Effects of fat and protein preloads on pouch emptying, intestinal transit, glycaemia, gut hormones, glucose absorption, blood pressure and gastrointestinal symptoms after Roux-en-Y gastric bypass. Obes Surg. 2016;26:77–84.
pubmed: 25986427 doi: 10.1007/s11695-015-1722-7
Carswell KA, Vincent RP, Belgaumkar AP, et al. The effect of bariatric surgery on intestinal absorption and transit time. Obes Surg. 2014;24:796–805.
pubmed: 24374942 doi: 10.1007/s11695-013-1166-x
Wang G, Agenor K, Pizot J, et al. Accelerated gastric emptying but no carbohydrate malabsorption 1 year after gastric bypass surgery (GBP). Obes Surg. 2012;22:1263–7.
pubmed: 22527599 pmcid: 3659340 doi: 10.1007/s11695-012-0656-6
Morínigo R, Moizé V, Musri M, et al. Glucagon-Like Peptide-1, Peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab. 2006;91:1735–40.
pubmed: 16478824 doi: 10.1210/jc.2005-0904
Falkén Y, Hellström PM, Holst JJ, et al. Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides. J Clin Endocrinol Metab. 2011;96:2227–35.
pubmed: 21543426 doi: 10.1210/jc.2010-2876
Sarosiek I, Selover KH, Katz LA, et al. The assessment of regional gut transit times in healthy controls and patients with gastroparesis using wireless motility technology. Aliment Pharmacol Ther. 2010;31:313–22.
pubmed: 19814743
Wang YT, Mohammed SD, Farmer AD, et al. Regional gastrointestinal transit and pH studied in 215 healthy volunteers using the wireless motility capsule: influence of age, gender, study country and testing protocol. Aliment Pharmacol Ther. 2015;42:761–72.
pubmed: 26223837 doi: 10.1111/apt.13329
Farmer AD, Pedersen AG, Brock B, et al. Type 1 diabetic patients with peripheral neuropathy have pan-enteric prolongation of gastrointestinal transit times and an altered caecal pH profile. Diabetologia. 2017;60:709–18.
pubmed: 28105520 doi: 10.1007/s00125-016-4199-6
Farmer AD, Wegeberg A-ML, Brock B, et al. Regional gastrointestinal contractility parameters using the wireless motility capsule: inter-observer reproducibility and influence of age, gender and study country. Aliment Pharmacol Ther. 2018;47:391–400.
pubmed: 29210098 doi: 10.1111/apt.14438
Portney LG, Watkins MP. Foundations of clinical research: applications to practice. 3rd ed. Pearson/Prentice Hall: Upper Saddle River; 2009.
Abuhelwa AY, Williams DB, Upton RN, et al. Food, gastrointestinal pH, and models of oral drug absorption. Eur J Pharm Biopharm. 2017;112:234–48.
pubmed: 27914234 doi: 10.1016/j.ejpb.2016.11.034
Berg P, McCallum R. Dumping syndrome: a review of the current concepts of pathophysiology, diagnosis, and treatment. Dig Dis Sci. 2016;61:11–8.
pubmed: 26396002 doi: 10.1007/s10620-015-3839-x
Megan D. What is hypochlorhydria. Healthline Media. 2018 [cited 2019 Oct 2]. Available from: https://www.healthline.com/health/hypochlorhydria .  Accessed 2 Oct 2020.
Camilleri M, Malagelada J-R. Abnormal intestinal motility in diabetics with the gastroparesis syndrome. Eur J Clin Investig. 1984;14:420–7.
doi: 10.1111/j.1365-2362.1984.tb01206.x
Faria M, Pavin EJ, Parisi MCR, et al. Delayed small intestinal transit in patients with long-standing type 1 diabetes mellitus: investigation of the relationships with clinical features, gastric emptying, psychological distress, and nutritional parameters. Diabetes Technol Ther. 2013;15:32–8.
pubmed: 23126582 doi: 10.1089/dia.2012.0158
Nguyen NQ, Debreceni TL, Burgstad CM, et al. Effects of posture and meal volume on gastric emptying, intestinal transit, oral glucose tolerance, blood pressure and gastrointestinal symptoms after Roux-en-Y gastric bypass. Obes Surg. 2015;25:1392–400.
pubmed: 25502436 doi: 10.1007/s11695-014-1531-4
Näslund I, Beckman K-W. Gastric emptying rate after gastric bypass and gastroplasty. Scand J Gastroenterol. 1987;22:193–201.
pubmed: 3554493 doi: 10.3109/00365528708991879
Jacobsen SH, Bojsen-Møller KN, Dirksen C, et al. Effects of gastric bypass surgery on glucose absorption and metabolism during a mixed meal in glucose-tolerant individuals. Diabetologia. 2013;56:2250–4.
pubmed: 23893303 doi: 10.1007/s00125-013-3003-0
Martinussen C, Bojsen-Møller KN, Dirksen C, et al. Augmented GLP-1 secretion as seen after gastric bypass may be obtained by delaying carbohydrate digestion. J Clin Endocrinol Metab. 2019;104:3233–44.
pubmed: 30844053 doi: 10.1210/jc.2018-02661
Bojsen-Møller KN, Jacobsen SH, Dirksen C, et al. Accelerated protein digestion and amino acid absorption after Roux-en-Y gastric bypass. Am J Clin Nutr. 2015;102:600–7.
pubmed: 26245808 doi: 10.3945/ajcn.115.109298
Farmer AD, Mohammed SD, Dukes GE, et al. Caecal pH is a biomarker of excessive colonic fermentation. World J Gastroenterol. 2014;20:5000–7.
pubmed: 24803812 pmcid: 4009533 doi: 10.3748/wjg.v20.i17.5000
Hasler WL, Saad RJ, Rao SS, et al. Heightened colon motor activity measured by a wireless capsule in patients with constipation: relation to colon transit and IBS. Am J Physiol Gastrointest Liver Physiol. 2009;297:G1107–14.
pubmed: 19808653 doi: 10.1152/ajpgi.00136.2009
Poulsen JL, Nilsson M, Brock C, et al. The impact of opioid treatment on regional gastrointestinal transit. J Neurogastroenterol Motil. 2016;22:282–91.
pubmed: 26811503 pmcid: 4819867 doi: 10.5056/jnm15175
Müller M, Canfora EE, Blaak EE. Gastrointestinal transit time, glucose homeostasis and metabolic health: modulation by dietary fibers. Nutrients. 2018;10:275.
pmcid: 5872693 doi: 10.3390/nu10030275 pubmed: 5872693
Afshar S, Kelly SB, Seymour K, et al. The effects of bariatric procedures on bowel habit. Obes Surg. 2016;26:2348–54.
pubmed: 26894909 pmcid: 5018031 doi: 10.1007/s11695-016-2100-9
Potoczna N, Harfmann S, Steffen R, et al. Bowel habits after bariatric surgery. Obes Surg. 2008;18:1287–96.
pubmed: 18327626 doi: 10.1007/s11695-008-9456-4
Titus R, Kastenmeier A, Otterson MF. Consequences of gastrointestinal surgery on drug absorption. Nutr Clin Pract. 2013;28:429–36.
pubmed: 23835364 doi: 10.1177/0884533613490740
Seeley RJ, Chambers AP, Sandoval DA. The role of gut adaptation in the potent effects of multiple bariatric surgeries on obesity and diabetes. Cell Metab. 2015;21:369–78.
pubmed: 25662404 pmcid: 25662404 doi: 10.1016/j.cmet.2015.01.001
Bohlin J, Dahlin E, Dreja J, et al. Longer colonic transit time is associated with laxative and drug use, lifestyle factors, and symptoms of constipation. Acta Radiol Open. 2018;7:205846011880723.
doi: 10.1177/2058460118807232
Roager HM, Hansen LBS, Bahl MI, et al. Colonic transit time is related to bacterial metabolism and mucosal turnover in the gut. Nat Microbiol. 2016;1:16093.
pubmed: 27562254 doi: 10.1038/nmicrobiol.2016.93
Saad RJ. The wireless motility capsule: a one-stop shop for the evaluation of GI motility disorders. Curr Gastroenterol Rep. 2016;18:14.
pubmed: 26908282 doi: 10.1007/s11894-016-0489-x
Wright RA, Krinsky S, Fleeman C, et al. Gastric emptying and obesity. Gastroenterology. 1983;84:747–51.
pubmed: 6825986 doi: 10.1016/0016-5085(83)90141-5
Al Mushref M, Srinivasan S. Effect of high fat-diet and obesity on gastrointestinal motility. Ann Transl Med. 2013;1:14.
pubmed: 24432301 pmcid: 3890396
Vazquez Roque MI, Camilleri M, Stephens DA, et al. Gastric sensorimotor functions and hormone profile in normal weight, overweight, and obese people. Gastroenterology. 2006;131:1717–24.
pubmed: 17087952 doi: 10.1053/j.gastro.2006.10.025
Doran S, Jones KL, Andrews JM, et al. Effects of meal volume and posture on gastric emptying of solids and appetite. Am J Physiol. 1998;275:R1712–8.
pubmed: 9791094
Velchik MG, Reynolds JC, Alavi A. The effect of meal energy content on gastric emptying. J Nucl Med. 1989;30:1106–10.
pubmed: 2738691

Auteurs

Louise Ladebo (L)

Mech-Sense, Department of Gastroenterology and Hepatology, Aalborg University Hospital, Medicinerhuset 4th floor, Mølleparkvej 4, DK-9000, Aalborg, Denmark. louiseladebo@gmail.com.
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. louiseladebo@gmail.com.

Pernille V Pedersen (PV)

Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

Grzegorz J Pacyk (GJ)

Department of Clinical Medicine and Endocrinology, Aalborg University Hospital, Aalborg, Denmark.

Jens Peter Kroustrup (JP)

Department of Clinical Medicine and Endocrinology, Aalborg University Hospital, Aalborg, Denmark.

Asbjørn M Drewes (AM)

Mech-Sense, Department of Gastroenterology and Hepatology, Aalborg University Hospital, Medicinerhuset 4th floor, Mølleparkvej 4, DK-9000, Aalborg, Denmark.
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

Christina Brock (C)

Mech-Sense, Department of Gastroenterology and Hepatology, Aalborg University Hospital, Medicinerhuset 4th floor, Mølleparkvej 4, DK-9000, Aalborg, Denmark.
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

Anne E Olesen (AE)

Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Department of Clinical Pharmacology, Aalborg University Hospital, Aalborg, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH